AM6 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Amicus Therapeutics Inc

Watchlist Manager

Watchlist

Price: 12.295 EUR Market Closed

Market Cap: €3.6B

A	Amicus Therapeutics Inc F:AM6	US
A	Amrapali Industries Ltd BSE:526241	IN
	Ryoden Corp TSE:8084	JP

Profitability Summary

Amicus Therapeutics Inc's profitability score is 27/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

89%

Strong 3Y Average Gross Margin

90%

Declining Gross Margin

89% > 89%

Low Operating Margin

Negative 3Y Average Operating Margin

-4%

Operating Margin is Increasing

-38% > 5%

Negative Net Margin

-4%

Negative 3Y Average Net Margin

-20%

Net Margin is Increasing

-53% > -4%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-11%

Free Cash Flow Margin is Increasing

-38% > 5%

Negative ROE

-12%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-82%

Declining ROIC

-30% > -852%

View All

Hide

Collapse

27 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

89%

Strong 3Y Average Gross Margin

90%

Declining Gross Margin

89% > 89%

Low Operating Margin

Negative 3Y Average Operating Margin

-4%

Operating Margin is Increasing

-38% > 5%

Negative Net Margin